Leverage Single-Cell Multi-Omics for a Comprehensive Understanding of AML, PDX Model Validation, and Therapeutic Development
Time: 12:00 pm
day: Applications for Efficacy Evaluation & Biomarker Discovery Day 1 AM
Details:
- Case studies leveraging single-cell DNA + protein multi-omics to understand AML disease evolution, treatment response, and mechanisms of resistance.
- How PDX models and sample multiplexing were used for baseline and end-point analysis in AML samples.
- Introducing a novel single-cell multiomics approach to dissect disease models, reduce downstream clinical trial costs and failure rates.
